” The upgraded outcomes enhance the capacity of Rina-S and additional confirm our advancement strategy in innovative ovarian cancer cells,” claims Genmab’s Principal Growth Police officer.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/genmab-reports-promising-data-in-ovarian-and-pelvic-cancer-treatment-study/